Publication:2905114
From MaRDI portal
zbMath1257.62005MaRDI QIDQ2905114
Publication date: 24 August 2012
coherence; model selection; hypothesis testing; Bayes factor; Bayesian model selection; foundations of statistics; evidential support; direct likelihood; likelihoodism
62P10: Applications of statistics to biology and medical sciences; meta analysis
92C40: Biochemistry, molecular biology
92D10: Genetics and epigenetics
62J15: Paired and multiple comparisons; multiple testing
62A99: Foundational topics in statistics
Related Items
Bayesian revision of a prior given prior-data conflict, expert opinion, or a similar insight: a large-deviation approach, Model fusion and multiple testing in the likelihood paradigm: shrinkage and evidence supporting a point null hypothesis, Rejoinder, Coherent Hypothesis Testing, Statistical evidence and surprise unified under possibility theory, The \(p\)-value interpreted as the posterior probability of explaining the data: applications to multiple testing and to restricted parameter spaces, A prior-free framework of coherent inference and its derivation of simple shrinkage estimators, Inference after checking multiple Bayesian models for data conflict and applications to mitigating the influence of rejected priors, Self-consistent confidence sets and tests of composite hypotheses applicable to restricted parameters, Controlling the degree of caution in statistical inference with the Bayesian and frequentist approaches as opposite extremes, The sufficiency of the evidence, the relevancy of the evidence, and quantifying both with a single number, Coherent checking and updating of Bayesian models without specifying the model space: a decision-theoretic semantics for possibility theory, A measure of evidence based on the likelihood-ratio statistics, Pseudo-likelihood, explanatory power, and Bayes's theorem [Comment on: ``A likelihood paradigm for clinical trials], A classical measure of evidence for general null hypotheses, A frequentist framework of inductive reasoning, Estimating the Null Distribution to Adjust Observed Confidence Levels for Genome-Scale Screening
Uses Software
